Newsletter | October 9, 2025

10.09.25 -- Rapid Testing Gains Momentum In Cell Therapy

Advances In Analytical Method Selection And Technology Transfer

Adopting current best practices is critical to helping mitigate risks like production delays and compliance penalties in manufacturing. Learn about effective strategies that can streamline your analytical method transfer process.

 

Molecular Approaches To Streamline Cell Therapy Product Analytical Testing

Traditional compendial safety and impurity tests can take days or weeks to process. Learn how rapid molecular methods like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.

 

Ensuring Product Safety And Purity With Mycoplasma And Sterility Testing

Rapid qPCR testing provides a sensitive, accurate, and streamlined alternative to 28-day culture methods for mycoplasma and sterility testing in cell therapy manufacturing. This rapid turnaround supports greater workflow efficiency and improved risk mitigation.

 

Streamlining Data For Efficient Therapeutic Manufacturing

Achieving regulatory compliance for biotherapeutics requires streamlined analysis. Learn how automated, integrated software can simplify complex data from residual DNA and contaminant assays, providing actionable results while ensuring data traceability and compliance.

 

SOLUTIONS

Cell Therapy Analytical Testing Solutions

Accelerate cell therapy release testing with rapid molecular methods that deliver same-day, actionable results. Discover available solutions for product safety, quality, and potency analysis.

• Request Information

 

 

 

Molecular-Based Detection And Testing

Move past slow, growth-based assays. Molecular-based testing offers rapid, accurate detection of contaminants, ensuring patient safety and accelerating the delivery of safe, effective cell therapies.

• Request Information